We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTT icon
2001
inTEST
INTT
$143M
$588K ﹤0.01%
28,349
+13,532
+91% +$203K
GSAT icon
2002
Globalstar
GSAT
$10.1B
$587K ﹤0.01%
33,752
+21,612
+178% +$398K
CHKP icon
2003
Check Point Software Technologies
CHKP
$14.3B
$587K ﹤0.01%
4,515
-186,963
-98% -$23.8M
VGASW icon
2004
CALL
Verde Clean Fuels Warrant
VGASW
$507K
$586K ﹤0.01%
86,809
AMBP icon
2005
Ardagh Metal Packaging
AMBP
$2.96B
$584K ﹤0.01%
143,256
-171,975
-55% -$844K
FDMT icon
2006
4D Molecular Therapeutics
FDMT
$502M
$584K ﹤0.01%
33,954
-35,793
-51% -$696K
ECC
2007
Eagle Point Credit Company
ECC
$497M
$583K ﹤0.01%
+52,211
New +$566K
MOBVW
2008
CALL
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$578K ﹤0.01%
55,372
-88,938
-62% -$4.2K
IHAK icon
2009
iShares Cybersecurity and Tech ETF
IHAK
$988M
$578K ﹤0.01%
15,889
-3,442
-18% -$118K
WDS icon
2010
Woodside Energy
WDS
$44.2B
$575K ﹤0.01%
+25,652
New +$616K
TRCA.WS
2011
CALL
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$574K ﹤0.01%
56,026
BBJP icon
2012
JPMorgan BetaBuilders Japan ETF
BBJP
$17B
$572K ﹤0.01%
11,826
-29,888
-72% -$1.4M
MRUS
2013
DELISTED
Merus
MRUS
$572K ﹤0.01%
31,100
CPSS icon
2014
Consumer Portfolio Services
CPSS
$209M
$572K ﹤0.01%
53,497
-31,465
-37% -$320K
UDR icon
2015
UDR
UDR
$12.8B
$572K ﹤0.01%
+13,925
New +$575K
SNBR
2016
DELISTED
Sleep Number
SNBR
$572K ﹤0.01%
18,796
-6,162
-25% -$201K
FHLC icon
2017
Fidelity MSCI Health Care Index ETF
FHLC
$3.35B
$567K ﹤0.01%
9,222
-4,478
-33% -$278K
VIA
2018
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$565K ﹤0.01%
30,731
-5,502
-15% -$155K
NWG icon
2019
NatWest
NWG
$69.9B
$564K ﹤0.01%
+85,431
New +$603K
USX
2020
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$564K ﹤0.01%
+94,900
New +$222K
EWJ icon
2021
PUT
iShares MSCI Japan ETF
EWJ
$21.2B
$563K ﹤0.01%
+9,600
New +$547K
HMC icon
2022
Honda
HMC
$39.8B
$563K ﹤0.01%
+21,269
New +$534K
ORIAW
2023
CALL
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$563K ﹤0.01%
54,995
MITK icon
2024
Mitek Systems
MITK
$756M
$561K ﹤0.01%
58,499
-30,247
-34% -$290K
NRGV icon
2025
Energy Vault
NRGV
$455M
$559K ﹤0.01%
+261,390
New +$891K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.